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Objectives: Obstructive sleep apnea (OSA) is a sleep disorder with repeated nocturnal desaturation and
sleep fragmentation. It can lead to poor quality of life. Our goal was to compare improvement in the
quality of life of patients with OSA between those treated with continuous positive airway pressure
(CPAP) and autotitrating positive airway pressure (APAP) for 3 months.
Materials and Methods: This was a prospective, randomized, crossover study. Study participants were
patients with OSA randomized into the APAP or CPAP group, with crossover to the other group 3 months
later. All patients received CPAP or APAP treatment for > 4 h/d. Each patient completed the Short Form 36
Health Survey (SF-36) before and after the 3-month CPAP and APAP treatment.
Results: The 19 patients had severe OSA [mean apneaehypopnea index (AHI) 59.7 ± 23.9/h] and the
mean optimal pressure of CPAP titration was 8.7 ± 1.5 mmHg. The CPAP group had a higher mean
pressure 8.7 ± 1.4 mmHg as well as a lower AHI 0.6 ± 1.4/h than the APAP group. There was no difference
in compliance between groups. Both groups had signiﬁcant improvement in general health and vitality
after treatment compared with before treatment. However, there were no signiﬁcant differences in
improvement in any component of the SF-36 between groups.
Conclusion: In our study, the CPAP patients had a higher pressure and lower AHI than the APAP patients.
OSA patients preferred APAP. Both CPAP and APAP can improve general health and vitality in OSA
patients.
Copyright © 2015, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Obstructive sleep apnea syndrome (OSA) involves recurrent
upper airway collapse leading to repetitive episodes of hypoxemia
and arousal during sleep [1]. Its clinical features include snoring,
daytime sleepiness, and sleep fragmentation [2]. There is increasing
evidence that poor sleep quality can lead to an inability to maintain
daytime wakefulness and poor quality of life [3].icine, Buddhist Tzu Chi Gen-
ien, Taiwan. Tel: þ886 3 865
T. Chang).
elief Tzu Chi Foundation. PublisheContinuous positive airway pressure (CPAP) and autotitrating
positive airway pressure (APAP) are now standard treatments for
patients with OSA, with good evidence that they improve cogni-
tive function and quality of life [4,5]. Improvement in quality of
life with short-term use of CPAP/APAP (from 6 weeks to 3 months)
has been well reported in patients with good compliance to
treatment in some studies [6]. However, the rate of discontinuing
CPAP has ranged from 8% to 46% [7]. One meta-analysis showed
that APAP improved compliance in OSA patients by 11 min/night
[6]. To our knowledge, few studies have investigated the differ-
ences in quality of life with long-term use of CPAP/APAP. Our study
investigated the compliance and improvement in quality of life
over 6 months in OSA patients with good compliance to APAP/
CPAP.d by Elsevier Taiwan LLC. All rights reserved.
Table 1
Demographic and polysomnographic data.
n (M/F) 19 (18/1)
Age (y) 46.2 ± 16.5
BMI (kg/m2) 30.2 ± 4.6
NC (cm) 40.6 ± 2.8
ESS 9.6 ± 5.0
AHI (/h) 59.7 ± 23.9
TST (min) 343.0 ± 71.0
SE (%) 81.8 ± 16.0
N1 (%) 43.9 ± 20.2
N2 (%) 31.6 ± 17.4
N3 (%) 5.9 ± 8.3
REM (%) 18.6 ± 7.5
AI (/h) 43.4 ± 20.4
ODI (/h) 52.5 ± 39.6
CPAPP (mmHg) 8.7 ± 1.5
Data are shown as mean ± standard deviation.
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This prospective, randomized, crossover study enrolled 25 pa-
tients with moderate-to-severe OSA [apneaehypopnea index
(AHI)  15/h] from the Sleep Center of Hualien Tzu Chi General
Hospital, Hualien, Taiwan in 2012. The patients were randomly
divided into the CPAP or APAP group for 3 months. After 3 months,
the patients shifted to the alternative treatment for the following 3
months. All study participants completed Short Form 36 Health
Survey (SF-36) questionnaires at baseline (before treatment) and at
3 months and 6 months after different positive airway pressure
treatments. Patients younger than 20 years and those who were
under treatment for anxiety and depression were excluded. The
hospital's Institutional Review Board approved the study. The study
had no external funding. All participants provided informed
consent.AHI ¼ apneaehypopnea index; AI ¼ arousal index;
BMI ¼ body mass index; CPAPP ¼ pressure deﬁned by
continuous positive airway pressure titration;
ESS ¼ Epworth sleepiness scale; N1 ¼ NREM stage 1;
N2 ¼ NREM stage 2; N3 ¼ NREM stage 3; NC ¼ neck
circumference; ODI ¼ oxygen desaturation index;
REM ¼ rapid eye movement stage; SE ¼ sleep efﬁcacy;
TST ¼ total sleep time.2.1. Polysomnography and CPAP titration study
All patients underwent one night of polysomnographic study
(A10; Embla, Broomﬁeld, CO, USA) at the Sleep Center. A CPAP
titration study was performed on each patient with moderate-to-
severe OSA (AHI  15/h), with manual methods by H.M.W. The
optimal CPAP pressure was deﬁned as the pressure at which the
AHI 5/h during the CPAP titration study. Patients in the CPAP/
APAP treatment group used the DeZire OminiPAP OP700 (MD
Biomedical Inc., Taipei, Taiwan, R.O.C.).2.2. Data collection
Patient information obtained included age, sex, bodymass index
(BMI), Epworth sleepiness scale (ESS) score, and polysomnographic
proﬁles. All study participants also completed the SF-36 at baseline
(before treatment) and at 3 months and 6 months after the
different treatments. The compliance data, including number of
hours used, number of days used, and mean pressure of the CPAP/
APAP, as well as the AHI under PAP treatment were recorded by the
smart card from the CPAP/APAP equipment.2.3. Statistical analysis
Analysis was performed using the SPSS version 14.0 (SPSS Inc.,
Chicago, IL, USA). Post hoc analysis was applied to compare the
order effects of the SF-36 pre- and post-treatment with APAP/CPAP.
Statistical signiﬁcance was set at p < 0.05.Table 2
Compliances between autotitrating positive airway pressure (APAP) and continuous
positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) patients.
CPAP APAP
mP (mmHg) 8.7 ± 1.4 * 7.5 ± 1.6
Hours 5.8 ± 1.2 6.3 ± 1.5
Days used 50.1 ± 5.5 49.6 ± 6.1
AHI 0.6 ± 1.4 * 2.4 ± 1.8
Data are shown as mean ± standard deviation.
*p < 0.05 compared to APAP group.
AHI ¼ apneaehypopnea index; mP ¼ mean pressure during 90% of positive airway
pressure treatment.3. Results
Six of the 25 enrolled OSA patients (24%; 3 received APAP ﬁrst
and 3 received CPAP ﬁrst) withdrew during the 1st month due to
intolerance to CPAP/APAP. Nineteen patients (76%; male/female, 18/
1) completed all 6 months of treatment. All of the enrolled OSA
patients used CPAP/APAP for > 4 h/d, as well as > 70% of the studied
days. Patients who were enrolled initially in either the CPAP or
APAP group did not change their compliance during the following
3-month treatment with CPAP/APAP.
The mean age of the studied patients was 46.2 ± 16.5 years,
mean body mass index was 30.2 ± 4.6 kg/m2, and mean ESS score
was 9.6 ± 5.0. Polysomnographic data from the 19 patients showed
a mean AHI of 59.7 ± 23.9/h, with a mean arousal index of
43.4 ± 20.4/h andmean oxygen desaturation index of 52.5 ± 39.6/h.
The mean CPAP pressure deﬁned by the CPAP titration pressure
study was 8.7 ± 1.5 mmHg (Table 1).3.1. Compliance
The APAP group had a nonsigniﬁcant increase in hours using
treatment per day (0.3 ± 1.2 h/d, 17 minutes) compared with the
CPAP group. The mean pressure during CPAP was 1.2 mmHg higher
and the AHI was signiﬁcantly lower by 1.8/h than in the APAP group
although both treatment groups had an AHI < 5/h during treatment
(Table 2).
3.2. Quality of life
Eight components of the SF-36 were collected in the studied
group. There were signiﬁcant improvements in the scores for
general health (GH) and vitality (VT) after CPAP and APAP treat-
ment compared with pretreatment. However, these two compo-
nents did not show signiﬁcant differences between groups
(Table 3). Compared with pretreatment, GH scores improved a
mean 15.1 points in the CPAP group and 12.5 points in APAP group,
and VT scores improved 14.7 points in CPAP group and 14.5 points
in APAP group. Improvements in both GH and VT on the SF-36 did
not have signiﬁcant correlations with improvement in the AHI.
4. Discussion
In the present randomized, crossover study, CPAP and APAP
equally improved quality of life after 3 months treatment in OSA
patients, as shown by the GH and VT scores on the SF-36. APAP was
Table 3
Comparison of quality of life with SF-36 measurements before and after autoti-
trating positive airway pressure (APAP) and continuous positive airway pressure
(CPAP) treatment of obstructive sleep apnea (OSA) patients.
Before treatment CPAP APAP
PF 85.5 ± 11.9 84.2 ± 16.8 83.9 ± 15.6
RP 59.2 ± 39.3 77.6 ± 34.2 81.6 ± 29.9
BP 74.9 ± 14.6 74.4 ± 17.2 82.9 ± 18.6
GH 49.5 ± 17.1 b,c 64.6 ± 18.0 a 62.2 ± 18.4 a
VT 49.7 ± 17.0 b,c 64.4 ± 17.7 a 64.2 ± 17.0 a
SF 76.9 ± 17.3 75.0 ± 19.1 80.3 ± 18.8
RE 57.9 ± 41.3 73.7 ± 39.4 71.9 ± 43.4
MH 61.3 ± 11.9 66.5 ± 12.9 68.0 ± 12.9
Data are shown as mean ± standard deviation.
BP ¼ bodily pain; GH ¼ General health; MH ¼ mental health; PF ¼ physical func-
tioning; RE ¼ role-emotional; RP ¼ role-physical; SF ¼ social functioning;
VT ¼ vitality.
a p < 0.05 compared to OSA patients before treatment.
b p < 0.05 compared to OSA patients under CPAP treatment for 3 months.
c p < 0.05 compared to OSA patients under APAP treatment for 3 months.
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CPAP had signiﬁcantly better effects in minimizing the AHI in OSA
patients because of a higher mean pressure during positive airway
pressure treatment. Initial use of CPAP or APAP did not affect
further use of CPAP and APAP after 1 month of treatment.
Most previous studies showed no difference between the use of
APAP or CPAP, but some showed better compliance with APAP. In a
meta-analysis [6], OSA patients who used APAP had a statistically
signiﬁcant difference of 11 minutes use per night. The clinical sig-
niﬁcance of improvement in compliance with APAP was unclear in
the previous report. Similarly, those who used APAP in our study
could tolerate it for about 17 minutes longer at night than CPAP, but
this was not signiﬁcant, probably because of the small number of
patients. Although CPAP had a higher mean pressure overnight, the
effect of a minimized AHI was better with CPAP than APAP in our
study.
Quality of life is often assessed in OSA patients. In the Sleep
Heart Health Study [8], patients with mild to moderate OSA had
reduced vitality, while a poorer quality of life was noted in patients
with severe OSA. Daytime sleepiness has been associated with poor
quality of life in OSA patients. In another study, depression, lower
arterial oxygen saturation during sleep and higher ESS scores were
associated with poor quality of life [9]. In the meta-analysis [6],there were no signiﬁcant differences in quality of life measures
between APAP and CPAP treatment. Improvements in vitality,
mental health, and physical health were seen in the SF-36 of OSA
patients who had been treated for 1 month to 6 weeks [9]. In the
present study, therewere no differences in improvement on the SF-
36 between the CPAP and APAP groups, and the main improve-
ments were seen in VTand GH in treated patients. Improvements in
both VT and GH were greater than the minimally important clinical
differences (an increase of > 5 in the score for each component). To
our knowledge, our study had the longest follow-up period in
crossover studies of OSA patients. However, the study had limita-
tions due to the small number of patients studied. Power analysis
calculation showed that 28 patients were needed to compare the
two groups. Larger sample sizes study should be used in future
studies.
In conclusion, CPAP had a higher pressure and lower AHI than
APAP. OSA patients preferred to use APAP. Both CPAP and APAP can
improve GH and VT in OSA patients.References
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